Conrad has over 3 decades experience with technology ventures in a wide variety of exec, non-exec and advisory roles. He was founding chair of medical-AI venture Blackford Analysis (acquired by Bayer in 2023) and CPTO of medical-imaging company Voxar (acquired in 2004). He currently advises various tech ventures, and is an Entrepreneur-in-Residence at Heriot-Watt university.